Traditionally designed clinical trials continue to be challenged by two key issues in regard to recruitment and enrollment: difficulty enrolling enough patients and a lack of representativeness in enrolled patient populations.
In general, traditionally designed, site-based studies rely on recruiting patients from a set geography that would allow for regular visits to clinics. This approach naturally limits the pool of potential study participants, but it also locks studies into whatever level of population diversity (or lack thereof) is prevalent in that set study geography.
Using digital tools and effective DCT approaches, research stakeholders can significantly improve access to studies for both patients and sites, helping to increase the numbers of eligible participants in clinical research and the representativeness of patient populations. More diverse participant groups that better reflect the real-world population lead to better, more comprehensive data on the safety and efficacy of new therapies.